Efforts are underway to standardize personalized CRISPR gene-editing therapies, which may lead to faster and safer treatments. The development of these therapies is progressing, with some outlets reporting promising results, including a successful treatment of a baby with a rare disease. However, the timeline for when these therapies will become widely available to patients, particularly those with rare diseases, remains uncertain.